ConductScience.org, home

Paper25399643

Targeting protein kinases with selective and semipromiscuous covalent inhibitors.

Miller RM and 1 other. Methods Enzymol, 2014. Cited by 31 papers, by iCite.

Cite this record

ConductScience Library. Targeting protein kinases with selective and semipromiscuous covalent inhibitors. Papers, record 25399643. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25399643

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Targeting protein kinases with selective and semipromiscuous covalent inhibitors.
PubMed
Journal
Methods Enzymol
PubMed
Year
2014
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
31
iCite
Relative citation ratio, by iCite
0.86
iCite
Revised in PubMed
2018-11-13
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Miller RMRand M
2Taunton JJack

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Drug DesignMajor topic
Models, ChemicalMajor topic
Protein Kinase InhibitorsMajor topic
Protein KinasesMajor topic
Animals
Biocatalysis
Catalysis
Catalytic Domain
Humans
Lysine
Protein Conformation

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R01 GM071434NIGMS NIH HHSUnited StatesR01GM071434PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References49

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
116868029RSK and MSK in MAP kinase signalling.J Cell Sci2006https://conductscience.org/library/papers/16868029PubMed
216763566The mTOR/PI3K and MAPK pathways converge on eIF4B to control its phosphorylation and activity.EMBO J2006https://conductscience.org/library/papers/16763566PubMed
317154430Discovery of selective irreversible inhibitors for Bruton's tyrosine kinase.ChemMedChem2007https://conductscience.org/library/papers/17154430PubMed
417259979A clickable inhibitor reveals context-dependent autoactivation of p90 RSK.Nat Chem Biol2007https://conductscience.org/library/papers/17259979PubMed
517142297
Evidence for direct regulation of myocardial Na+/H+ exchanger isoform 1 phosphorylation and activity by 90-kDa ribosomal S6 kinase (RSK): effects of the novel and specific RSK inhibitor fmk on responses to alpha1-adrenergic stimulation.
Mol Pharmacol2007https://conductscience.org/library/papers/17142297PubMed
617721511Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors.Nat Biotechnol2007https://conductscience.org/library/papers/17721511PubMed
717850214The selectivity of protein kinase inhibitors: a further update.Biochem J2007https://conductscience.org/library/papers/17850214PubMed
819716794RSK is a principal effector of the RAS-ERK pathway for eliciting a coordinate promotile/invasive gene program and phenotype in epithelial cells.Mol Cell2009https://conductscience.org/library/papers/19716794PubMed
920338520A structure-guided approach to creating covalent FGFR inhibitors.Chem Biol2010https://conductscience.org/library/papers/20338520PubMed
1020234090p90 ribosomal S6 kinase 2 promotes invasion and metastasis of human head and neck squamous cell carcinoma cells.J Clin Invest2010https://conductscience.org/library/papers/20234090PubMed
1121062900A genome-wide RNAi screen identifies multiple RSK-dependent regulators of cell migration.Genes Dev2010https://conductscience.org/library/papers/21062900PubMed
1221322567Cysteine mapping in conformationally distinct kinase nucleotide binding sites: application to the design of selective covalent inhibitors.J Med Chem2011https://conductscience.org/library/papers/21322567PubMed
1321455239The resurgence of covalent drugs.Nat Rev Drug Discov2011https://conductscience.org/library/papers/21455239PubMed
1421627121Irreversible Nek2 kinase inhibitors with cellular activity.J Med Chem2011https://conductscience.org/library/papers/21627121PubMed
1521700206In situ kinase profiling reveals functionally relevant properties of native kinases.Chem Biol2011https://conductscience.org/library/papers/21700206PubMed
1621765410High-frequency genome editing using ssDNA oligonucleotides with zinc-finger nucleases.Nat Methods2011https://conductscience.org/library/papers/21765410PubMed
1722187936Regulation and function of the RSK family of protein kinases.Biochem J2012https://conductscience.org/library/papers/22187936PubMed
1822284350How chemoproteomics can enable drug discovery and development.Chem Biol2012https://conductscience.org/library/papers/22284350PubMed
1922466421Reversible targeting of noncatalytic cysteines with chemically tuned electrophiles.Nat Chem Biol2012https://conductscience.org/library/papers/22466421PubMed
2022621397Irreversible protein kinase inhibitors: balancing the benefits and risks.J Med Chem2012https://conductscience.org/library/papers/22621397PubMed

See all 49 referencesDownload CSV of references

Cited by16

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 31 citations.

PMIDTitleJournalYearIn PapersSource
40964339High throughput screening of eukaryotic release factor 1 variants to enhance noncanonical amino acid incorporation.bioRxiv2025https://conductscience.org/library/papers/40964339PubMed
39366946Reversible covalent c-Jun N-terminal kinase inhibitors targeting a specific cysteine by precision-guided Michael-acceptor warheads.Nat Commun2024https://conductscience.org/library/papers/39366946PubMed
39366929Targeting a key protein-protein interaction surface on mitogen-activated protein kinases by a precision-guided warhead scaffold.Nat Commun2024https://conductscience.org/library/papers/39366929PubMed
36793448Bioconjugate Platform for Iterative Backbone N-Methylation of Peptides.ACS Catal2022https://conductscience.org/library/papers/36793448PubMed
35364007Inhibiting a dynamic viral protease by targeting a non-catalytic cysteine.Cell Chem Biol2022https://conductscience.org/library/papers/35364007PubMed
32042200Development of a covalent inhibitor of gut bacterial bile salt hydrolases.Nat Chem Biol2020https://conductscience.org/library/papers/32042200PubMed
30974337Future prospects for noncanonical amino acids in biological therapeutics.Curr Opin Biotechnol2019https://conductscience.org/library/papers/30974337PubMed
30837567Regional perturbation of gene transcription is associated with intrachromosomal rearrangements and gene fusion transcripts in high grade ovarian cancer.Sci Rep2019https://conductscience.org/library/papers/30837567PubMed
30533581The Allosteric Site on SHP2's Protein Tyrosine Phosphatase Domain is Targetable with Druglike Small Molecules.ACS Omega2018https://conductscience.org/library/papers/30533581PubMed
29626545Hypoxia-selective allosteric destabilization of activin receptor-like kinases: A potential therapeutic avenue for prophylaxis of heterotopic ossification.Bone2018https://conductscience.org/library/papers/29626545PubMed
28920684Stilbene Boronic Acids Form a Covalent Bond with Human Transthyretin and Inhibit Its Aggregation.J Med Chem2017https://conductscience.org/library/papers/28920684PubMed
28701380Prediction of intracellular exposure bridges the gap between target- and cell-based drug discovery.Proc Natl Acad Sci U S A2017https://conductscience.org/library/papers/28701380PubMed
28640596Drug-Target Kinetics in Drug Discovery.ACS Chem Neurosci2018https://conductscience.org/library/papers/28640596PubMed
27598117The Search for Covalently Ligandable Proteins in Biological Systems.Molecules2016https://conductscience.org/library/papers/27598117PubMed
27059428Modular Synthesis of Novel Macrocycles Bearing α,β-Unsaturated Chemotypes through a Series of One-Pot, Sequential Protocols.Chemistry2016https://conductscience.org/library/papers/27059428PubMed
26159564Automated computational screening of the thiol reactivity of substituted alkenes.J Comput Aided Mol Des2015https://conductscience.org/library/papers/26159564PubMed

Download CSV of cited by

Genes17

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/25399643

GET https://conductscience.org/api/papers/v1/25399643/references?page=2